{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:17:18Z","timestamp":1791296238457,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2011,11,25]],"date-time":"2011-11-25T00:00:00Z","timestamp":1322179200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,11,25]],"date-time":"2011-11-25T00:00:00Z","timestamp":1322179200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1038\/leu.2011.305","type":"journal-article","created":{"date-parts":[[2011,11,25]],"date-time":"2011-11-25T09:56:28Z","timestamp":1322214988000},"page":"1064-1072","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":162,"title":["The miRNA-17\u223c92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K\/AKT pathway activation"],"prefix":"10.1038","volume":"26","author":[{"given":"E","family":"Rao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Lenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L M","family":"Staudt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T W","family":"McKeithan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W C","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,11,25]]},"reference":[{"key":"BFleu2011305_CR1","volume-title":"Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","author":"ES Jaffe","year":"2001","unstructured":"Jaffe ES, Harris NL, Stein H, Vardiman J . Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues, 1st edn. IARC Press: Lyon, 2001."},{"key":"BFleu2011305_CR2","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/(SICI)1097-0142(19980201)82:3<567::AID-CNCR20>3.0.CO;2-Z","volume":"82","author":"F Bosch","year":"1998","unstructured":"Bosch F, Lopez-Guillermo A, Campo E, Ribera JM, Conde E, Piris MA et al. Mantle cell lymphoma: presenting features, response to therapy, and prognostic factors. Cancer 1998; 82: 567\u2013575.","journal-title":"Cancer"},{"key":"BFleu2011305_CR3","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/315340a0","volume":"315","author":"Y Tsujimoto","year":"1985","unstructured":"Tsujimoto Y, Jaffe E, Cossman J, Gorham J, Nowell PC, Croce CM . Clustering of breakpoints on chromosome 11 in human B-cell neoplasms with the t(11;14) chromosome translocation. Nature 1985; 315: 340\u2013343.","journal-title":"Nature"},{"key":"BFleu2011305_CR4","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1002\/j.1460-2075.1994.tb06488.x","volume":"13","author":"SE Bodrug","year":"1994","unstructured":"Bodrug SE, Warner BJ, Bath ML, Lindeman GJ, Harris AW, Adams JM . Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. EMBO J 1994; 13: 2124\u20132130.","journal-title":"EMBO J"},{"key":"BFleu2011305_CR5","doi-asserted-by":"publisher","first-page":"3487","DOI":"10.1002\/j.1460-2075.1994.tb06655.x","volume":"13","author":"H Lovec","year":"1994","unstructured":"Lovec H, Grzeschiczek A, Kowalski MB, Moroy T . Cyclin D1\/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice. EMBO J 1994; 13: 3487\u20133495.","journal-title":"EMBO J"},{"key":"BFleu2011305_CR6","first-page":"594","volume":"84","author":"I Wlodarska","year":"1999","unstructured":"Wlodarska I, Pittaluga S, Hagemeijer A, De Wolf-Peeters C, Van Den Berghe H . Secondary chromosome changes in mantle cell lymphoma. Haematologica 1999; 84: 594\u2013599.","journal-title":"Haematologica"},{"key":"BFleu2011305_CR7","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1200\/JCO.2006.08.4251","volume":"25","author":"I Salaverria","year":"2007","unstructured":"Salaverria I, Zettl A, Bea S, Moreno V, Valls J, Hartmann E et al. Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature. J Clin Oncol 2007; 25: 1216\u20131222.","journal-title":"J Clin Oncol"},{"key":"BFleu2011305_CR8","doi-asserted-by":"publisher","first-page":"3087","DOI":"10.1158\/0008-5472.CAN-03-3773","volume":"64","author":"A Ota","year":"2004","unstructured":"Ota A, Tagawa H, Karnan S, Tsuzuki S, Karpas A, Kira S et al. Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. Cancer Res 2004; 64: 3087\u20133095.","journal-title":"Cancer Res"},{"key":"BFleu2011305_CR9","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/nature03552","volume":"435","author":"L He","year":"2005","unstructured":"He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S et al. A microRNA polycistron as a potential human oncogene. Nature 2005; 435: 828\u2013833.","journal-title":"Nature"},{"key":"BFleu2011305_CR10","doi-asserted-by":"publisher","first-page":"9628","DOI":"10.1158\/0008-5472.CAN-05-2352","volume":"65","author":"Y Hayashita","year":"2005","unstructured":"Hayashita Y, Osada H, Tatematsu Y, Yamada H, Yanagisawa K, Tomida S et al. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 2005; 65: 9628\u20139632.","journal-title":"Cancer Res"},{"key":"BFleu2011305_CR11","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nature03677","volume":"435","author":"KA O\u2019Donnell","year":"2005","unstructured":"O\u2019Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT . c-Myc-regulated microRNAs modulate E2F1 expression. Nature 2005; 435: 839\u2013843.","journal-title":"Nature"},{"key":"BFleu2011305_CR12","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1038\/ng1855","volume":"38","author":"M Dews","year":"2006","unstructured":"Dews M, Homayouni A, Yu D, Murphy D, Sevignani C, Wentzel E et al. Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat Genet 2006; 38: 1060\u20131065.","journal-title":"Nat Genet"},{"key":"BFleu2011305_CR13","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.ydbio.2007.08.007","volume":"310","author":"Y Lu","year":"2007","unstructured":"Lu Y, Thomson JM, Wong HY, Hammond SM, Hogan BL . Transgenic over-expression of the microRNA miR-17-92 cluster promotes proliferation and inhibits differentiation of lung epithelial progenitor cells. Dev Biol 2007; 310: 442\u2013453.","journal-title":"Dev Biol"},{"key":"BFleu2011305_CR14","doi-asserted-by":"publisher","first-page":"7071","DOI":"10.1158\/0008-5472.CAN-09-1095","volume":"69","author":"A Navarro","year":"2009","unstructured":"Navarro A, Bea S, Fernandez V, Prieto M, Salaverria I, Jares P et al. MicroRNA expression, chromosomal alterations, and immunoglobulin variable heavy chain hypermutations in Mantle cell lymphomas. Cancer Res 2009; 69: 7071\u20137078.","journal-title":"Cancer Res"},{"key":"BFleu2011305_CR15","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.cell.2008.02.019","volume":"132","author":"A Ventura","year":"2008","unstructured":"Ventura A, Young AG, Winslow MM, Lintault L, Meissner A, Erkeland SJ et al. Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 2008; 132: 875\u2013886.","journal-title":"Cell"},{"key":"BFleu2011305_CR16","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.cell.2008.02.020","volume":"132","author":"SB Koralov","year":"2008","unstructured":"Koralov SB, Muljo SA, Galler GR, Krek A, Chakraborty T, Kanellopoulou C et al. Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage. Cell 2008; 132: 860\u2013874.","journal-title":"Cell"},{"key":"BFleu2011305_CR17","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/ni1575","volume":"9","author":"C Xiao","year":"2008","unstructured":"Xiao C, Srinivasan L, Calado DP, Patterson HC, Zhang B, Wang J et al. Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat Immunol 2008; 9: 405\u2013414.","journal-title":"Nat Immunol"},{"key":"BFleu2011305_CR18","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/j.1365-2141.2005.05630.x","volume":"130","author":"EG Rizzatti","year":"2005","unstructured":"Rizzatti EG, Falcao RP, Panepucci RA, Proto-Siqueira R, Anselmo-Lima WT, Okamoto OK et al. Gene expression profiling of mantle cell lymphoma cells reveals aberrant expression of genes from the PI3K-AKT, WNT and TGFbeta signalling pathways. Br J Haematol 2005; 130: 516\u2013526.","journal-title":"Br J Haematol"},{"key":"BFleu2011305_CR19","doi-asserted-by":"publisher","first-page":"3722","DOI":"10.1182\/blood-2004-10-3999","volume":"105","author":"IM Ghobrial","year":"2005","unstructured":"Ghobrial IM, McCormick DJ, Kaufmann SH, Leontovich AA, Loegering DA, Dai NT et al. Proteomic analysis of mantle-cell lymphoma by protein microarray. Blood 2005; 105: 3722\u20133730.","journal-title":"Blood"},{"key":"BFleu2011305_CR20","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1182\/blood-2006-04-015586","volume":"108","author":"M Rudelius","year":"2006","unstructured":"Rudelius M, Pittaluga S, Nishizuka S, Pham TH, Fend F, Jaffe ES et al. Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphoma. Blood 2006; 108: 1668\u20131676.","journal-title":"Blood"},{"key":"BFleu2011305_CR21","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.1182\/blood-2009-06-222794","volume":"114","author":"Y Yamanaka","year":"2009","unstructured":"Yamanaka Y, Tagawa H, Takahashi N, Watanabe A, Guo YM, Iwamoto K et al. Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer-cell lymphoma\/leukemia. Blood 2009; 114: 3265\u20133275.","journal-title":"Blood"},{"key":"BFleu2011305_CR22","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1101\/gad.1861409","volume":"23","author":"V Olive","year":"2009","unstructured":"Olive V, Bennett MJ, Walker JC, Ma C, Jiang I, Cordon-Cardo C et al. miR-19 is a key oncogenic component of mir-17-92. Genes Dev 2009; 23: 2839\u20132849.","journal-title":"Genes Dev"},{"key":"BFleu2011305_CR23","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S1535-6108(03)00028-X","volume":"3","author":"A Rosenwald","year":"2003","unstructured":"Rosenwald A, Wright G, Wiestner A, Chan WC, Connors JM, Campo E et al. The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell 2003; 3: 185\u2013197.","journal-title":"Cancer Cell"},{"key":"BFleu2011305_CR24","doi-asserted-by":"publisher","first-page":"13520","DOI":"10.1073\/pnas.0804295105","volume":"105","author":"G Lenz","year":"2008","unstructured":"Lenz G, Wright GW, Emre NC, Kohlhammer H, Dave SS, Davis RE et al. Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways. Proc Natl Acad Sci USA 2008; 105: 13520\u201313525.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2011305_CR25","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005; 102: 15545\u201315550.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2011305_CR26","first-page":"3301","volume":"26","author":"K Legarza","year":"2006","unstructured":"Legarza K, Yang LX . New molecular mechanisms of action of camptothecin-type drugs. Anticancer Res 2006; 26: 3301\u20133305.","journal-title":"Anticancer Res"},{"key":"BFleu2011305_CR27","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/S0092-8674(03)01018-3","volume":"115","author":"BP Lewis","year":"2003","unstructured":"Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB . Prediction of mammalian microRNA targets. Cell 2003; 115: 787\u2013798.","journal-title":"Cell"},{"key":"BFleu2011305_CR28","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nmeth1079","volume":"4","author":"MS Ebert","year":"2007","unstructured":"Ebert MS, Neilson JR, Sharp PA . MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat Methods 2007; 4: 721\u2013726.","journal-title":"Nat Methods"},{"key":"BFleu2011305_CR29","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1038\/sj.leu.2403942","volume":"19","author":"H Tagawa","year":"2005","unstructured":"Tagawa H, Seto M . A microRNA cluster as a target of genomic amplification in malignant lymphoma. Leukemia 2005; 19: 2013\u20132016.","journal-title":"Leukemia"},{"key":"BFleu2011305_CR30","doi-asserted-by":"publisher","first-page":"13375","DOI":"10.1074\/jbc.273.22.13375","volume":"273","author":"T Maehama","year":"1998","unstructured":"Maehama T, Dixon JE . The tumor suppressor, PTEN\/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 1998; 273: 13375\u201313378.","journal-title":"J Biol Chem"},{"key":"BFleu2011305_CR31","doi-asserted-by":"publisher","first-page":"5699","DOI":"10.1073\/pnas.93.12.5699","volume":"93","author":"M Andjelkovic","year":"1996","unstructured":"Andjelkovic M, Jakubowicz T, Cron P, Ming XF, Han JW, Hemmings BA . Activation and phosphorylation of a pleckstrin homology domain containing protein kinase (RAC-PK\/PKB) promoted by serum and protein phosphatase inhibitors. Proc Natl Acad Sci USA 1996; 93: 5699\u20135704.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2011305_CR32","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.molcel.2007.02.017","volume":"25","author":"J Brognard","year":"2007","unstructured":"Brognard J, Sierecki E, Gao T, Newton AC . PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms. Mol Cell 2007; 25: 917\u2013931.","journal-title":"Mol Cell"},{"key":"BFleu2011305_CR33","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.molcel.2007.03.007","volume":"25","author":"MC Mendoza","year":"2007","unstructured":"Mendoza MC, Blenis J . PHLPPing it off: phosphatases get in the Akt. Mol Cell 2007; 25: 798\u2013800.","journal-title":"Mol Cell"},{"key":"BFleu2011305_CR34","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1093\/emboj\/17.2.384","volume":"17","author":"L O\u2019Connor","year":"1998","unstructured":"O\u2019Connor L, Strasser A, O\u2019Reilly LA, Hausmann G, Adams JM, Cory S et al. Bim: a novel member of the Bcl-2 family that promotes apoptosis. Embo J 1998; 17: 384\u2013395.","journal-title":"Embo J"},{"key":"BFleu2011305_CR35","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.molcel.2004.12.030","volume":"17","author":"L Chen","year":"2005","unstructured":"Chen L, Willis SN, Wei A, Smith BJ, Fletcher JI, Hinds MG et al. Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell 2005; 17: 393\u2013403.","journal-title":"Mol Cell"},{"key":"BFleu2011305_CR36","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1126\/science.1133289","volume":"315","author":"SN Willis","year":"2007","unstructured":"Willis SN, Fletcher JI, Kaufmann T, van Delft MF, Chen L, Czabotar PE et al. Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak. Science 2007; 315: 856\u2013859.","journal-title":"Science"},{"key":"BFleu2011305_CR37","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1038\/sj.onc.1208300","volume":"24","author":"H Tagawa","year":"2005","unstructured":"Tagawa H, Karnan S, Suzuki R, Matsuo K, Zhang X, Ota A et al. Genome-wide array-based CGH for mantle cell lymphoma: identification of homozygous deletions of the proapoptotic gene BIM. Oncogene 2005; 24: 1348\u20131358.","journal-title":"Oncogene"},{"key":"BFleu2011305_CR38","doi-asserted-by":"publisher","first-page":"6164","DOI":"10.1073\/pnas.0401471101","volume":"101","author":"A Egle","year":"2004","unstructured":"Egle A, Harris AW, Bouillet P, Cory S . Bim is a suppressor of Myc-induced mouse B cell leukemia. Proc Natl Acad Sci USA 2004; 101: 6164\u20136169.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2011305_CR39","doi-asserted-by":"publisher","first-page":"5024","DOI":"10.4049\/jimmunol.168.10.5024","volume":"168","author":"M Stahl","year":"2002","unstructured":"Stahl M, Dijkers PF, Kops GJ, Lens SM, Coffer PJ, Burgering BM et al. The forkhead transcription factor FoxO regulates transcription of p27Kip1 and Bim in response to IL-2. J Immunol 2002; 168: 5024\u20135031.","journal-title":"J Immunol"},{"key":"BFleu2011305_CR40","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1084\/jem.20060353","volume":"203","author":"H You","year":"2006","unstructured":"You H, Pellegrini M, Tsuchihara K, Yamamoto K, Hacker G, Erlacher M et al. FOXO3a-dependent regulation of Puma in response to cytokine\/growth factor withdrawal. J Exp Med 2006; 203: 1657\u20131663.","journal-title":"J Exp Med"},{"key":"BFleu2011305_CR41","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1182\/blood-2003-09-3071","volume":"104","author":"I Yusuf","year":"2004","unstructured":"Yusuf I, Zhu X, Kharas MG, Chen J, Fruman DA . Optimal B-cell proliferation requires phosphoinositide 3-kinase-dependent inactivation of FOXO transcription factors. Blood 2004; 104: 784\u2013787.","journal-title":"Blood"},{"key":"BFleu2011305_CR42","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1182\/blood-2008-07-163907","volume":"113","author":"M Inomata","year":"2009","unstructured":"Inomata M, Tagawa H, Guo YM, Kameoka Y, Takahashi N, Sawada K . MicroRNA-17-92 down-regulates expression of distinct targets in different B-cell lymphoma subtypes. Blood 2009; 113: 396\u2013402.","journal-title":"Blood"},{"key":"BFleu2011305_CR43","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1002\/stem.84","volume":"27","author":"S Sengupta","year":"2009","unstructured":"Sengupta S, Nie J, Wagner RJ, Yang C, Stewart R, Thomson JA . MicroRNA 92b controls the G1\/S checkpoint gene p57 in human embryonic stem cells. Stem Cells 2009; 27: 1524\u20131528.","journal-title":"Stem Cells"},{"key":"BFleu2011305_CR44","doi-asserted-by":"publisher","first-page":"8233","DOI":"10.1158\/0008-5472.CAN-10-2412","volume":"70","author":"M Dews","year":"2010","unstructured":"Dews M, Fox JL, Hultine S, Sundaram P, Wang W, Liu YY et al. The myc-miR-17\u223c92 axis blunts TGF{beta} signaling and production of multiple TGF{beta}-dependent antiangiogenic factors. Cancer Res 2010; 70: 8233\u20138246.","journal-title":"Cancer Res"},{"key":"BFleu2011305_CR45","doi-asserted-by":"publisher","first-page":"5568","DOI":"10.1182\/blood-2008-10-185686","volume":"113","author":"AK Ghosh","year":"2009","unstructured":"Ghosh AK, Shanafelt TD, Cimmino A, Taccioli C, Volinia S, Liu CG et al. Aberrant regulation of pVHL levels by microRNA promotes the HIF\/VEGF axis in CLL B cells. Blood 2009; 113: 5568\u20135574.","journal-title":"Blood"},{"key":"BFleu2011305_CR46","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1074\/jbc.M608939200","volume":"282","author":"Y Sylvestre","year":"2007","unstructured":"Sylvestre Y, De Guire V, Querido E, Mukhopadhyay UK, Bourdeau V, Major F et al. An E2F\/miR-20a autoregulatory feedback loop. J Biol Chem 2007; 282: 2135\u20132143.","journal-title":"J Biol Chem"},{"key":"BFleu2011305_CR47","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1016\/j.ajpath.2011.06.008","volume":"179","author":"M Ji","year":"2011","unstructured":"Ji M, Rao E, Ramachandrareddy H, Shen Y, Jiang C, Chen J et al. The miR-17-92 MicroRNA Cluster Is Regulated by Multiple Mechanisms in B-Cell Malignancies. Am J Pathol 2011; 179: 1645\u20131656.","journal-title":"Am J Pathol"},{"key":"BFleu2011305_CR48","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1128\/MCB.01405-08","volume":"29","author":"M Bechard","year":"2009","unstructured":"Bechard M, Dalton S . Subcellular localization of glycogen synthase kinase 3beta controls embryonic stem cell self-renewal. Mol Cell Biol 2009; 29: 2092\u20132104.","journal-title":"Mol Cell Biol"},{"key":"BFleu2011305_CR49","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/S1074-7613(00)80388-X","volume":"7","author":"P Brennan","year":"1997","unstructured":"Brennan P, Babbage JW, Burgering BM, Groner B, Reif K, Cantrell DA . Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F. Immunity 1997; 7: 679\u2013689.","journal-title":"Immunity"},{"key":"BFleu2011305_CR50","doi-asserted-by":"publisher","first-page":"3957","DOI":"10.1096\/fj.09-131847","volume":"23","author":"I Manni","year":"2009","unstructured":"Manni I, Artuso S, Careccia S, Rizzo MG, Baserga R, Piaggio G et al. The microRNA miR-92 increases proliferation of myeloid cells and by targeting p63 modulates the abundance of its isoforms. FASEB J 2009; 23: 3957\u20133966.","journal-title":"FASEB J"},{"key":"BFleu2011305_CR51","doi-asserted-by":"publisher","first-page":"e2236","DOI":"10.1371\/journal.pone.0002236","volume":"3","author":"L Fontana","year":"2008","unstructured":"Fontana L, Fiori ME, Albini S, Cifaldi L, Giovinazzi S, Forloni M et al. Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM. PLoS One 2008; 3: e2236.","journal-title":"PLoS One"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2011305.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2011305","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2011305.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T14:42:13Z","timestamp":1648737733000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2011305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,25]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["BFleu2011305"],"URL":"https:\/\/doi.org\/10.1038\/leu.2011.305","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,25]]},"assertion":[{"value":"7 March 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}